Investing.com-- U.S. stock index futures were little changed on Monday evening after a mixed close on Wall Street, with gains ...

Investing.com -- Denny’s Corp (NASDAQ:DENN) stock surged 47.2% in after-hours trading Monday after the restaurant chain announced it has agreed to be acquired by a private investment group in an ...

BioNTech raised its full-year 2025 revenue guidance to €2.6-2.8 billion, up from its previous forecast of €1.7-2.2 billion ...

Cabot’s outlook for fiscal 2026 contributed to the negative market reaction, with the company projecting adjusted EPS of $6.00 to $7.00, compared to the $7.25 it achieved in fiscal 2025. The midpoint ...

Following the meeting, Trump said he had agreed to pause both heightened reciprocal levies on China and a separate plan to lift its duties on the country to 100%. The U.S. will also scale back its ...

S&P Global Ratings has upgraded Italian construction company Webuild SpA to ’BB+’ from ’BB’ with a stable outlook, citing improved credit metrics and solid operating performance. The rating agency ...

Silver mining stocks have shown remarkable strength throughout 2025, with several companies capitalizing on favorable market conditions. Using a combination of fair value assessments, Pro scores, ...

Investing.com -- Estrella Immunopharma Inc (NASDAQ:ESLA) stock surged 21.9% Monday after the clinical-stage biopharmaceutical company announced successful results from the second dose cohort in its ...

Investing.com -- Boqii Holding Ltd (NYSE:BQ) stock tumbled 16.8% on Monday after the pet-focused platform announced a registered direct offering that would raise approximately $4.2 million but dilute ...

Here are the top semiconductor stocks highlighted in Citi’s analysis: ...

Investing.com -- Questrade Financial Group Inc has secured a federal banking license from the Canadian banking regulator to launch its digital bank Questbank, the company announced Monday.

The U.S. Food and Drug Administration has granted Fast Track designation for fasedienol. VistaGen believes that successful results from either PALISADE-3 or PALISADE-4, combined with the positive ...